ACM
WST icon

Antonetti Capital Management’s West Pharmaceutical WST Stock Holding History

Antonetti Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$376 Hold
1
– – ﹤0.01% 313
2023
Q2 		$382 Sell
1
-3
-75% -$1.07K ﹤0.01% 316
2023
Q1 		$1.39K Buy
4
+3
+300% +$877 ﹤0.01% 293
2022
Q4 		$235 Hold
1
– – ﹤0.01% 331
2022
Q3 		$0 Hold
1
– – ﹤0.01% 358
2022
Q2 		$0 Hold
1
– – ﹤0.01% 359
2022
Q1 		$0 Sell
1
-29
-97% -$11.4K ﹤0.01% 410
2021
Q4 		$14K Hold
30
– – 0.01% 278
2021
Q3 		$13K Buy
+30
New +$12.6K 0.01% 290

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Antonetti Capital Management's WST Position: Q3 2023 in Review

Antonetti Capital Management held its West Pharmaceutical (WST) position steady in Q3 2023 at 1 share worth $376. The position accounts for ﹤0.01% of the portfolio, ranked #313.

Antonetti Capital Management first reported a position in WST in Q3 2021 and has held it in 9 quarters since. The position peaked at $14K in Q4 2021. 757 funds tracked by Wall St. Rank hold WST as of Q3 2023.

  • Antonetti Capital Management held 1 share of West Pharmaceutical worth $376 as of Q3 2023.
  • Antonetti Capital Management left its West Pharmaceutical share count unchanged in Q3 2023.
  • West Pharmaceutical made up ﹤0.01% of Antonetti Capital Management's portfolio in Q3 2023, its #313 holding.
  • Antonetti Capital Management first reported a position in West Pharmaceutical in Q3 2021 and has held it in 9 quarters since.
  • Antonetti Capital Management's West Pharmaceutical position peaked at $14K in Q4 2021.
  • 757 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2023.

Based on Antonetti Capital Management's 13F filing for Q3 2023, filed 9 Nov 2023.